<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0005110'>Atrial fibrillation</z:hpo> (AF) is a risk factor for <z:e sem="disease" ids="C0007780" disease_type="Disease or Syndrome" abbrv="">cerebral embolism</z:e>, with the left atrial appendage (LAA) being considered as the source of emboli </plain></SENT>
<SENT sid="1" pm="."><plain>However, the relationship between the histologic properties of LAA <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> and the occurrence of <z:e sem="disease" ids="C0007780" disease_type="Disease or Syndrome" abbrv="">cerebral embolism</z:e> is not known </plain></SENT>
<SENT sid="2" pm="."><plain>Seventy-six hearts from patients who died within 1 month after <z:e sem="disease" ids="C0007780" disease_type="Disease or Syndrome" abbrv="">cerebral embolism</z:e> were studied at autopsy </plain></SENT>
<SENT sid="3" pm="."><plain>Patients were grouped according to the presence of AF and the presence of valvular disease (VD) </plain></SENT>
<SENT sid="4" pm="."><plain>We determined whether the LAA <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> adhered to the trabecular region or the remainder of the LAA </plain></SENT>
<SENT sid="5" pm="."><plain>LAA <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> were grouped into three stages: a fresh stage in which <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> consisted of fibrin and platelets, an organizing stage in which <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> was observed in the <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e>, and an organized stage in which endothelial cells covered the surface of the <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>The AF+/VD- group included 19 patients (25.0%), the AF+/VD+ group 8 (10.5%), the AF-/ VD- group 37 (48.7%), and the AF-/VD+ group included 12 patients (15.8%) </plain></SENT>
<SENT sid="7" pm="."><plain>LAA <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> were observed in 15 patients (78.9%) in the AF+/VD- group, and <z:hpo ids='HP_0000001'>all</z:hpo> of the <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> adhered to the trabecular region </plain></SENT>
<SENT sid="8" pm="."><plain><z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">Thrombi</z:e> in the fresh and the organizing stages were observed in 10 patients (66.7%) </plain></SENT>
<SENT sid="9" pm="."><plain>Patients in the AF+/VD- group accounted for about 25% of the cases of <z:e sem="disease" ids="C0007780" disease_type="Disease or Syndrome" abbrv="">cerebral embolism</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> of these <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> were attached to the trabecular region, and about 70% of them could represent an embolic source </plain></SENT>
</text></document>